The Current Ratio as of June 2025 (TTM) for Almirall, S.A. (LBTSF) is 2.10

According to Almirall, S.A.’s latest financial reports and current stock price. The company's current Current Ratio is 2.10. This represents a change of -14.33% compared to the average of 2.45 of the last 4 quarters.

Almirall, S.A. (LBTSF) Historical Current Ratio (quarterly & annually)

How has LBTSF Current Ratio performed in the past?

The mean historical Current Ratio of Almirall, S.A. over the last ten years is 1.94. The current 2.10 Current Ratio has changed 10.69% with respect to the historical average. Over the past ten years (40 quarters), LBTSF's Current Ratio was at its highest in in the December 2015 quarter at 3.80. The Current Ratio was at its lowest in in the March 2022 quarter at 0.

Almirall, S.A. (LBTSF) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Almirall, S.A. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Almirall, S.A. (LBTSF) Average Current Ratio

How has LBTSF Current Ratio performed in the past?

The current Current Ratio of Almirall, S.A. (LBTSF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Almirall, S.A. (LBTSF) Current Ratio vs. Peers

How is LBTSF’s Current Ratio compared to its peers?

Almirall, S.A.’s Current Ratio is greater than RAMM Pharma Corp. (1.46), less than North Bud Farms Inc. (4.48), greater than CanaQuest Medical Corp. (0.15), greater than City View Green Holdings Inc. (0.00), greater than Craftport Cannabis Corp. (0.03), less than Ironwood Pharmaceuticals, Inc. (0), less than Alkermes plc (3.34), less than Eagle Pharmaceuticals, Inc. (3.33), greater than ANI Pharmaceuticals, Inc. (1.70), less than Aquestive Therapeutics, Inc. (2.66), less than Intra-Cellular Therapies, Inc. (4.87), less than Catalent, Inc. (6.36), less than Amphastar Pharmaceuticals, Inc. (2.51), less than Alvotech (2.95), greater than Assertio Holdings, Inc. (1.73), greater than Shuttle Pharmaceuticals Holdings, Inc. (1.66), less than Alimera Sciences, Inc. (2.78), less than Lifecore Biomedical, Inc. (2.79), less than Petros Pharmaceuticals, Inc. (2.71), greater than null (0.53),

Build a custom stock screener for Almirall, S.A. (LBTSF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Almirall, S.A. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Almirall, S.A. (LBTSF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Almirall, S.A. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.